New antiepileptic drugs, cost-efficacy analysis

New antiepileptic drugs, cost-efficacy analysis

Objective: to optimize pharmacotherapy in patients with epilepsy and to evaluate the clinical and cost-effectiveness of its therapy with the new antiepileptic drugs (AED): levetiracetam, lamotrigine, topiramate, and oxcarbazepine.Patients and methods. The study enrolled 134 patients (women, 69.03%;...

Full description

Bibliographic Details
Main Authors: P. N. Vlasov, N. V. Orekhova, T. I. Konovalova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-01-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
epilepsy
levetiracetam
lamotrigine
topiramate
oxcarbazepine
cost-efficacy
Online Access:https://nnp.ima-press.net/nnp/article/view/226

Internet

https://nnp.ima-press.net/nnp/article/view/226

Similar Items